Predictions
Stratec SE
Start price
Target price
Perf. (%)
€122.40
30.12.20
30.12.20
€128.00
30.12.21
30.12.21
12.75%
31.12.21
31.12.21
Could be worthwhile Investment >10% per year
Kontron AG
Start price
Target price
Perf. (%)
€14.30
16.12.21
16.12.21
-
16.12.22
16.12.22
11.61%
27.12.21
27.12.21
Could be worthwhile Investment >10% per year
Kontron AG
Start price
Target price
Perf. (%)
€14.30
16.12.21
16.12.21
-
16.12.22
16.12.22
11.61%
27.12.21
27.12.21
Could be worthwhile Investment >10% per year
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€30.15
25.12.20
25.12.20
€50.00
25.12.21
25.12.21
104.98%
26.12.21
26.12.21
Could be worthwhile Investment >10% per year
VERBIO Vereinigte BioEnergie AG
Start price
Target price
Perf. (%)
€30.15
25.12.20
25.12.20
€50.00
25.12.21
25.12.21
104.98%
26.12.21
26.12.21
Could be worthwhile Investment >10% per year
Adaptimmune Therapeutics PLC ADR
Start price
Target price
Perf. (%)
€3.26
12.12.21
12.12.21
-
12.12.22
12.12.22
9.82%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.60
12.12.21
12.12.21
-
12.12.22
12.12.22
23.60%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Molecular Templates Inc.
Start price
Target price
Perf. (%)
€3.32
12.12.21
12.12.21
-
12.12.22
12.12.22
2.65%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Novavax Inc.
Start price
Target price
Perf. (%)
€151.40
12.12.21
12.12.21
-
12.12.22
12.12.22
5.67%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
12.12.21
12.12.21
-
12.12.22
12.12.22
8.73%
25.12.21
25.12.21
Could be very worthwhile Investment >20% year
Esperion Therapeutis.Inc.
Start price
Target price
Perf. (%)
€4.66
12.12.21
12.12.21
-
12.12.22
12.12.22
-1.27%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Puma Biotechnology Inc.
Start price
Target price
Perf. (%)
€2.48
12.12.21
12.12.21
-
12.12.22
12.12.22
25.48%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Clovis Oncology Inc.
Start price
Target price
Perf. (%)
€2.49
12.12.21
12.12.21
-
12.12.22
12.12.22
4.74%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Cytomx Therapeutics Inc
Start price
Target price
Perf. (%)
€3.49
21.12.21
21.12.21
-
21.12.22
21.12.22
7.56%
25.12.21
25.12.21
Risky Investment
Radius Health Inc.
Start price
Target price
Perf. (%)
€6.70
12.12.21
12.12.21
-
12.12.22
12.12.22
-5.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
MacroGenics Inc.
Start price
Target price
Perf. (%)
€14.95
12.12.21
12.12.21
-
12.12.22
12.12.22
1.10%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Intra-Cellular Therapies Inc.
Start price
Target price
Perf. (%)
€32.60
16.12.21
16.12.21
-
16.12.22
16.12.22
38.19%
25.12.21
25.12.21
Could be worthwhile Investment >10% per year
Valneva SE
Start price
Target price
Perf. (%)
€23.36
11.12.21
11.12.21
€30.00
11.12.22
11.12.22
8.73%
25.12.21
25.12.21
Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
Minerva Neurosciences Inc.
Start price
Target price
Perf. (%)
€16.08
24.06.21
24.06.21
€4.80
24.06.22
24.06.22
-60.12%
20.12.21
20.12.21
Standard Investments for future growth
Higher EBIT margin than peer group
Very low/no dividend yield expected
ROE lower than 10% per year
Canadian Solar Inc.
Start price
Target price
Perf. (%)
€34.19
27.06.21
27.06.21
€34.00
27.06.22
27.06.22
-21.21%
20.12.21
20.12.21
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Plug Power Inc.
Start price
Target price
Perf. (%)
€24.98
18.12.20
18.12.20
€140.00
18.12.21
18.12.21
3.28%
19.12.21
19.12.21
Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group